Calendar

Week of Jan 4, 2016

Jan 5, 2016approval3871d agoGLIPIZIDE — FDA approvalGreenstone LLC

Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

Jan 5, 2016approval3871d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

Sponsor: GENUS. Form: SOLUTION. Route: ORAL

Jan 5, 2016approval3871d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL

Jan 5, 2016approval3871d agoOMEPRAZOLE — FDA approvalomeprazole DR

Sponsor: DEXCEL PHARMA. Form: TABLET, DELAYED RELEASE. Route: ORAL

Jan 6, 2016approval3870d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

Jan 8, 2016approval3868d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

Jan 10, 2016approval3866d agoROPINIROLE HYDROCHLORIDE — FDA approvalropinirole hydrochloride ER

Sponsor: ALEMBIC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

Jan 10, 2016approval3866d agoROPINIROLE HYDROCHLORIDE — FDA approvalropinirole hydrochloride ER

Sponsor: ALEMBIC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

Jan 12, 2016approval3864d agoULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approvalremifentanil hydrochloride

Sponsor: MYLAN INSTITUTIONAL. Form: INJECTABLE. Route: INJECTION

Jan 12, 2016approval

Jan 19, 2016approval3857d agoKESIMPTA (OFATUMUMAB) — FDA approvalKESIMPTA

Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

Jan 19, 2016approval

Jan 26, 2016approval3850d agoDUOPA (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ABBVIE. Form: SUSPENSION. Route: ENTERAL

Jan 26, 2016approval

← prev

page 1 of 608